EUVIMEDEUVIMED entdecken
Crossref

Leukocyte Esterase-Activated Nanoconjugates Enables Precise Local Therapy of Ulcerative Colitis via Inflamed Tissue-Selective Drug Delivery

Juho Lee, Aruzhan Saparbayeva, Jihyun Kim, Dongmin Kwak, Hyunwoo Kim, Muneeb Ullah, Md Lukman Hakim, Minjeong Kim, Eun Hee Lee iD, In-Soo Yoon iD, Min-Soo Kim, Yunjin Jung iD und 1 weitere

ACS Applied Materials & Interfaces · 24.09.2025 · 17 (38) · 53168-53179

DOI: 10.1021/acsami.5c11808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 11.09.2025. Verfasst von Juho Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Nanoconjugates, Dexamethasone, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukocyte esterase (LE), markedly upregulated in inflamed colonic tissues, offers a unique enzymatic trigger for selective drug activation in ulcerative colitis (UC). To exploit this pathological hallmark, we developed LE-activated nanoconjugates that enable inflamed tissue-selective drug delivery as a strategy to achieve precise local therapy for UC. Dexamethasone (DEX) was covalently conjugated to poly(lactide-co-glycolide) (PLGA) via ester bonds to form nanoconjugates (DPNCs) with suppressed drug release during gastrointestinal transit. These nanoconjugates accumulated in inflamed colonic tissues via the epithelial enhanced permeability and retention (eEPR) effect and selectively released DEX in response to elevated LE activity. In a dextran sulfate sodium-induced colitis model, orally administered DPNCs achieved superior colonic drug accumulation, minimized systemic distribution, and significantly improved therapeutic outcomes compared with free DEX. These findings highlight the potential of LE-activated nanoconjugates as an effective oral platform for precise and safe treatment of UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeNanoconjugatesDexamethasoneDrug Delivery SystemsAnti-Inflammatory AgentsAnimalsMicePolylactic Acid-Polyglycolic Acid CopolymerHumansDextran SulfateDrug Liberation

Stichwörter der Autor:innen

PLGAdexamethasoneinflamed tissue-selective drug deliveryleukocyte esteraseprecise local therapyulcerative colitis

Substanzen

NanoconjugatesDexamethasonePolylactic Acid-Polyglycolic Acid CopolymerDextran SulfateAnti-Inflammatory Agents

Autor:innen und Institutionen

  • College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
  • Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea.
  • College of Pharmacy, Korea University, Sejong 30019, Republic of Korea.

ORCID-Profile: Eun Hee Lee, In-Soo Yoon, Yunjin Jung, Jin-Wook Yoo

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, J., Saparbayeva, A., Kim, J., Kwak, D., Kim, H., Ullah, M., Hakim, M. L., Kim, M., Lee, E. H., Yoon, I. S., Kim, M. S., Jung, Y., & Yoo, J. W. (2025). Leukocyte Esterase-Activated Nanoconjugates Enables Precise Local Therapy of Ulcerative Colitis via Inflamed Tissue-Selective Drug Delivery. ACS Applied Materials & Interfaces, 17(38), 53168-53179. https://doi.org/10.1021/acsami.5c11808

Vancouver

Lee J, Saparbayeva A, Kim J, Kwak D, Kim H, Ullah M, et al. Leukocyte Esterase-Activated Nanoconjugates Enables Precise Local Therapy of Ulcerative Colitis via Inflamed Tissue-Selective Drug Delivery. ACS Applied Materials & Interfaces. 2025;17(38):53168-53179. doi:10.1021/acsami.5c11808

BibTeX
@article{Lee2025,
  author = {Lee, Juho and Saparbayeva, Aruzhan and Kim, Jihyun and Kwak, Dongmin and Kim, Hyunwoo and Ullah, Muneeb and Hakim, Md Lukman and Kim, Minjeong and Lee, Eun Hee and Yoon, In-Soo and Kim, Min-Soo and Jung, Yunjin and Yoo, Jin-Wook},
  title = {Leukocyte Esterase-Activated Nanoconjugates Enables Precise Local Therapy of Ulcerative Colitis via Inflamed Tissue-Selective Drug Delivery},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  volume = {17},
  number = {38},
  pages = {53168--53179},
  doi = {10.1021/acsami.5c11808}
}
Kostenlos starten →